David A. Schwartz
Infectious Diseases · 2000–2020
A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 15 citations into it
Whom David A. Schwartz trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts David A. Schwartz overall
Papers from David A. Schwartz's perspective
Ordered by how strongly the researchers David A. Schwartz trusts endorse each paper. Same corpus, a different order for every researcher.
- Identification of severe acute respiratory syndrome in Canada. (New England Journal of Medicine)
- From SARS to MERS, Thrusting Coronaviruses into the Spotlight (Viruses)
- Another Decade, Another Coronavirus (New England Journal of Medicine)
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia (New England Journal of Medicine)
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome (The Lancet Respiratory Medicine)
- Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome (American Journal of Obstetrics and Gynecology)
- A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. (New England Journal of Medicine)
- Toll-like receptor 4 polymorphisms and atherogenesis. (New England Journal of Medicine)
- Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors (Nature)
- Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide (Journal of Experimental Medicine)
Their papers
- A guiding map for inflammation (2017) — 661 citations
- An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. (2020) — 828 citations
- Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections (2020) — 714 citations
- Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values (2012) — 420 citations
- A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis (2011) — 1,060 citations
- The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis (2005) — 596 citations
- A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. (2004) — 608 citations
- Toll-like receptors in the pathogenesis of human disease (2004) — 911 citations
- Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. (2002) — 632 citations
- Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement (2000) — 2,644 citations
- TLR4 mutations are associated with endotoxin hyporesponsiveness in humans (2000) — 2,161 citations